Explain this page
Arphra AIPlain-English read on Insmed Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $210.18 (+123.07%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.20% | -11.19% | -31.27% | -32.76% | -53.81% | -45.86% | +27.98% | +384.17% | +249.35% | +643.65% | -42.90% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$95.09
1 sh
Bid
$91.19
5 sh
Ask
$96.66
100 sh
Spread
$5.470
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
Top industries (issuer's industry highlighted)
- Biotechnology-1.63%
- Software - Infrastructure-6.40%
- Hardware, Equipment & Parts-4.84%
- Coal-4.45%
- Medical - Healthcare Information Services-4.41%
- REIT - Office+4.28%
- Broadcasting-4.23%
- Software - Application-4.13%
- Auto - Recreational Vehicles+4.13%
- Information Technology Services-3.97%
- Electronic Gaming & Multimedia-3.94%
- Oil & Gas Drilling-3.75%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)prnewswire.com·Jun 04, 2026
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)prnewswire.com·Jun 04, 2026
- Insmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Insmed Reports First-Quarter 2026 Financial Results and Provides Business Updateprnewswire.com·May 07, 2026
- Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasisprnewswire.com·May 06, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
Peers
No peer list available for INSM.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|